Get the latest Science News and Discoveries

FDA-Approved Nasal Spray For Depression Is First Of Its Kind

A ketamine-based nasal spray is officially the first and only standalone therapy available for treatment-resistant depression in the US.

None

Get the Android app

Or read this on Science Alert

Read more on:

Photo of Depression

Depression

Photo of kind

kind

Photo of approved nasal spray

approved nasal spray

Related news:

Empty headed? Largest study of its kind proves ‘bird brain’ is a misnomer - EurekAlert

How your brain learns from rewards might hold the key to treating depression

Ozempic-style drugs tied to more than 60 health benefits and risks in biggest study-of-its-kind

« SF's coyotes are going after an unexpected source of prey, new study shows — The highest overall contributor to coyote diets in San Francisco was anthropogenic, or human-origin, food, which was identified in 78% of the samples collected.